Ultima-Selank 5mg

MANUFACTURER Ultima Pharmaceuticals - USA
WAREHOUSE USA Warehouse 5
SUBSTANCE Selank

For your safety, all products are shipped without brand labels. The rapid advancements in biotechnology have opened new avenues for discovering innovative biologically-active compounds, including "cognitive enhancers" or "nootropics." One standout in this realm is Selank, previously known as "TP-7," a synthetic peptide that represents a small, artificially engineered protein.

Selank is acclaimed for its anti-anxiety properties and is also believed to improve learning and enhance energy levels, all purportedly without the risk of side effects or addiction.

As a relatively small synthetic peptide, Selank was developed through a collaboration between the Institute of Molecular Genetics and the V.V. Zakusov Research Institute of Pharmacology, both part of the Russian Academy of Sciences. This innovative compound was designed by combining tuftsin, a naturally occurring peptide that plays a role in immune response, with a sequence that boosts its molecular stability.

Research has indicated that both tuftsin and Selank can reduce anxiety and increase serotonin levels in animal models, with Selank showing enhanced effectiveness.

In Russia, Selank is approved for managing generalized anxiety disorder (GAD) and as a nootropic, although it has not received FDA approval for any medical conditions. Nonetheless, Selank is widely available in various countries, often marketed as a "nutritional supplement."

While the exact mechanisms of Selank are still under investigation, it is believed to stabilize enkephalins in the bloodstream, which are natural peptides that may help alleviate stress responses. However, some studies in mice have not confirmed this stabilization or demonstrated significant anti-anxiety benefits.

There is evidence suggesting that Selank may interact with GABA receptors, which are typically associated with sedative effects. Research involving mice has shown that Selank can enhance activity in GABA-dependent inhibitory neurons, leading to reduced overall brain activity, characteristic of sedative effects.

Additionally, Selank has been linked to increased levels of BDNF, a vital neurotropic factor involved in learning and memory, potentially explaining some of its claimed cognitive advantages.

Selank has also been shown to impact levels of neurotransmitters such as norepinephrine, dopamine, and serotonin in mice, all of which are crucial for motivation, focus, and pleasure. One study found that Selank increased norepinephrine while decreasing dopamine and serotonin levels, whereas other findings indicated it could elevate both norepinephrine and dopamine without affecting serotonin levels. This highlights the need for further research into its specific effects and mechanisms.

A preliminary clinical trial with 62 participants indicated that those treated with Selank reported reduced anxiety symptoms, particularly among individuals with pre-existing anxiety disorders. A similar study with 60 anxious patients found prolonged benefits lasting up to a week after the last dose. In another trial with 70 anxiety patients, Selank was observed to enhance the effects of phenazepam (an anti-anxiety medication banned in some U.S. states) while reportedly reducing side effects like drowsiness and memory impairment.

In animal studies, Selank displayed the ability to diminish anxiety in mice, with more anxious subjects showing significant behavioral improvements after treatment. Its anti-anxiety effects were also noted in rats treated daily for four weeks.

Though evidence is limited, it suggests Selank may help alleviate anxiety. However, further studies are needed to confirm its effectiveness and safety in humans. If you're experiencing anxiety, consult your doctor to determine if Selank might be beneficial?keeping in mind that this supplement should not replace prescribed treatments.

In a 30-day study, Selank was found to stabilize memory traces in rats, potentially enhancing memory retention, although the exact measurement methods remain unclear. Another study indicated that Selank might aid in preserving memory in monkeys.

Currently, there are no human studies available, and the effects of Selank on healthy individuals remain unknown, warranting caution until further research is conducted.

Research has shown that Selank can help normalize brain activity in rats suffering from toxin-induced damage.

Selank has been observed to alleviate depressive symptoms in mice, particularly showing greater effectiveness at lower doses.

In one animal study, Selank injections resulted in increased antioxidant levels in the livers of stressed mice.

In studies involving sedated cats, Selank was shown to reduce blood pressure by approximately 30% for up to three minutes and enhance cerebral blood flow by around 24% for up to ten minutes. While these findings suggest temporary cardiovascular effects, their significance remains uncertain, and these observations are limited to animals, leaving its effects on healthy humans unclear.

During alcohol withdrawal, anxiety is a common symptom. In a study simulating high alcohol consumption, rats treated with Selank reportedly experienced reduced anxiety after a 48-hour withdrawal period.

In another study, rats on a high-fat diet treated with Selank experienced 35% less weight gain, with total cholesterol levels dropping over 58% and blood glucose levels decreasing by 23.5%.

In a study involving breast cancer-affected mice, those receiving daily doses of Selank exhibited slower tumor growth and longer lifespans compared to untreated mice. However, this does not confirm Selank's anticancer efficacy, and extensive research is essential before considering it a viable cancer treatment option. It should never replace standard cancer therapies.

Post-treatment with Selank, increased levels of inflammatory response genes were noted in the spleens of mice, indicating potential protective benefits against inflammation.

Selank has been shown to reduce the size of stomach ulcers in animal models, likely by enhancing lymphatic flow to the stomach, which is crucial for immune function. However, comprehensive human studies are necessary to validate these effects and their underlying mechanisms.

Selank has been reported to raise IL-6 levels in blood cells from patients with depression. IL-6 is an inflammatory protein that may support infection resistance. Furthermore, in a cell-based study, Selank stimulated interferon release, which combats viruses.

While there are suggestions that Selank could protect against certain viral infections, results from an animal study involving virus-infected mice have raised doubts about its antiviral properties. Further research is needed to thoroughly evaluate Selank's potential and limitations.